Target intelligence / Profile preview

RNA, U6 small nuclear 941, pseudogene (RNU6-941P)

Target
RNU6-941P
Molecular classification
Other (Pseudogene), Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U6 small nuclear 941, pseudogene (RNU6-941P), is classified as a pseudogene of the U6 small nuclear RNA gene family[1]. U6 small nuclear RNA (snRNA) is a core component of the spliceosome, essential for pre-mRNA splicing in eukaryotic cells[5][3]. However, RNU6-941P is a non-functional, non-protein coding pseudogene variant and does not produce an active snRNA molecule. It is not implicated in disease mechanisms, therapeutic responses, or drug interactions. Like other U6 pseudogenes, it reflects the evolutionary duplication events common for snRNA genes in vertebrate genomes, underlining the biological importance of U6 function but not itself acting in any regulatory or structural biological capacity[1][5]. Supporting details: - U6 snRNA itself (but not its pseudogenes) is vital for the spliceosomal excision of introns from pre-mRNA[5][3]. - Pseudogenes, by definition, are generally not transcribed into functional products and lack biological activities attributed to their functional gene counterparts[1][5]. - RNU6-941P appears in genomic databases as a recognized pseudogene but with no associated protein, pathway, or disease annotation[1]. Therefore, RNU6-941P is not a drug target, does not encode a functional RNA or protein, and has no therapeutic or diagnostic significance.

Other names
RNU6-941PRNA, U6 small nuclear 941, pseudogene
02

Mechanism of action

None (not a therapeutic target)

03

Biological functions

None (pseudogene, does not have established biological function as an active RNA)
04

Disease associations

None known (no established involvement in disease; pseudogenes generally have no direct roles)

Beyond the preview

Go deeper on RNA, U6 small nuclear 941, pseudogene (RNU6-941P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 941, pseudogene (RNU6-941P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call